The expression of E2F7 was also found to be regulated by the activation of p53.<h4>Conclusions</h4>The high expression of E2F7, regulated by activated p53, confers chemoresistance to GBM cells by inhibiting drug uptake and DNA damage. The gene discussed is TP53; the disease is glioblastoma.